Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.

@article{Zachou2011MycophenolateFT,
  title={Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-na{\"i}ve patients.},
  author={Kalliopi Zachou and Nikolaos K. Gatselis and Georgia Papadamou and Eirini I Rigopoulou and George N Dalekos},
  journal={Journal of hepatology},
  year={2011},
  volume={55 3},
  pages={636-646}
}
BACKGROUND & AIMS Standard therapy for autoimmune hepatitis (AIH) is corticosteroids with or without azathioprine. However, 20% of patients do not respond or are intolerant to conventional treatment. Therefore, we evaluated prospectively the efficacy and safety of mycophenolate mofetil (MMF) in inducing and/or maintaining remission in treatment-naïve AIH… CONTINUE READING